Citrobacter freundii is a nosocomial opportunistic pathogen that can cause urinary and bloodstream infections. Phage therapies against C. freundii may prove useful in treating infections caused by this ubiquitous bacterium. Here, we report the complete genome of a T4-like myophage, Maroon, that infects C. freundii.
across the genome with many T4-like phages, such as Citrobacter phage Margaery (GenBank accession no. KT381880) and Cronobacter phage vB_CsaM_leB (GenBank accession no. KX431559) (sharing 99% and 94% DNA similarity, respectively). While 168 of the identified genes do not have a predicted function, proteins with annotated functions have homologs (via BLASTp against the NCBI nr database at an E value of Ͻ0.001) in T4 (GenBank accession no. NC_000866) or T4-like phages. Genes involved in DNA replication and nucleotide biosynthesis (DNA helicase, nrdA, nrdB, polynucleotide kinase, etc.) and virion morphogenesis (capsid proteins, tail fibers, tail sheath stabilizer, tail baseplate, etc.) were all identified. Lysis genes coding for a class III holin, a soluble L-alanyl-D-glutamate peptidase, and a separated spanin pair were also found.
Data availability. The genome sequence of phage Maroon was deposited under GenBank accession no. MH823906. The associated BioProject, SRA, and BioSample accession numbers are PRJNA222858, SRR8770019, and SAMN11233125, respectively.
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